• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Asymptomatic SARS-CoV-2 Vaccine Breakthrough Infections in Health Care Workers Identified Through Routine Universal Surveillance Testing

Mary Wilson

Well-known member
19 October 2021

https://doi.org/10.7326/M21-3486

Federica Novazzi, PhD, Stefano Taborelli, MD, Andreina Baj, MD, PhD, Daniele Focosi, MD, PhD, Fabrizio Maggi, MD, PhD

Background:
Concerns exist about the efficacy of COVID-19 vaccines against immune escape by viral variants of concern (VOCs): Delta is currently the most common VOC worldwide (1), and nasopharyngeal swabs (NPSs) show that fully vaccinated persons, like unvaccinated persons, harbor infectious viral loads (2). Reports to date have assessed the prevalence of vaccine breakthrough (VBT) infection among health care workers (HCWs), mostly based on spontaneous self-reporting by symptomatic HCWs and hence missing asymptomatic persons, who could nevertheless transmit the pathogen. Once a positive result is identified in an HCW, most countries ask for a 14-day quarantine or 2 consecutive follow-ups after at least 10 days before the HCW is admitted back to the workplace. Such mandatory quarantines can lead to large HCW shortages and cause health crises in hospitals.

https://www.acpjournals.org/doi/full/10.7326/M21-3486
 
Back
Top Bottom